6533b820fe1ef96bd1279b75
RESEARCH PRODUCT
Mitochondrial genetic haplogroups and cardiovascular diseases: Data from the Osteoarthritis Initiative
Patricia SchofieldBrendon StubbsAlberto VaonaStefania MaggiAi KoyanagiNicola VeroneseJacopo Demurtassubject
Male0301 basic medicineHeredityKneesCardiovascular MedicineBiochemistryHaplogroup0302 clinical medicineMedicine and Health SciencesMedicineLongitudinal StudiesProspective StudiesProspective cohort studyMusculoskeletal SystemEnergy-Producing Organelleseducation.field_of_studyMultidisciplinaryQHazard ratioRMiddle AgedOsteoarthritis KneeMitochondrial DNAMitochondriaNucleic acidsGenetic MappingGenes MitochondrialCardiovascular DiseasesResearch Design030220 oncology & carcinogenesisLegsMedicineFemaleCellular Structures and OrganellesAnatomyPolymorphism Restriction Fragment LengthResearch ArticleRiskmedicine.medical_specialtyForms of DNASciencecardiovascuar diseases (CVD)PopulationBioenergeticsResearch and Analysis MethodsLower riskDNA Mitochondrial03 medical and health sciencesRheumatologyInternal medicineOsteoarthritisGeneticsHumansGenetic Predisposition to DiseaseeducationAgedProportional Hazards ModelsEvolutionary BiologyPopulation Biologybusiness.industryProportional hazards modelArthritismitochondrial haplogroupHaplotypeBiology and Life SciencesCell BiologyDNA030104 developmental biologyHaplotypesCase-Control StudiesBody LimbsHaplogroupsbusinessPopulation GeneticsFollow-Up StudiesHuman mitochondrial DNA haplogroupdescription
Background Some case-control studies reported that mitochondrial haplogroups could be associated with the onset of cardiovascular diseases (CVD), but the literature regarding this topic is limited. We aimed to investigate whether any mitochondrial haplogroup carried a higher or lower risk of CVD in a large cohort of North American people affected by knee osteoarthritis or at high risk for this condition. Materials and methods A longitudinal cohort study including individuals from the Osteoarthritis Initiative was done. Haplogroups were assigned through a combination of sequencing and PCR-RFLP techniques. All the mitochondrial haplogroups have been named following this nomenclature: HV, JT, UK, IWX, and superHV/others. The strength of the association between mitochondrial haplogroups and incident CVD was evaluated through a Cox’s regression analysis, adjusted for potential confounders, and reported as hazard ratios (HRs) with their 95% confidence intervals (CIs). Results Overall, 3,288 Caucasian participants (56.8% women) with a mean age of 61.3±9.2 years without CVD at baseline were included. During a median follow-up of 8 years, 322 individuals (= 9.8% of baseline population) developed a CVD. After adjusting for 11 potential confounders at baseline and taking those with the HV haplotype as reference (the most frequent), those with JT carried a significant lower risk of CVD (HR = 0.75; 95%CI: 0.54–0.96; p = 0.03). Participants with the J haplogroup had the lowest risk of CVD (HR = 0.71; 95%CI: 0.46–0.95; p = 0.02). Conclusions The presence of JT haplogroups (particularly J) may be associated with a reduced risk of CVD. However, this result was not based on a high level of statistical significance. Thus, future research with larger sample size is needed to assess whether our results can be corroborated. © 2019 Veronese et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
year | journal | country | edition | language |
---|---|---|---|---|
2019-03-28 | PLOS ONE |